To define the cellular targetsfor c-kit ligand (KL) and to study their functional properties and composite antigenic profile, we isolated cells expressing c-kit receptor (KR) from bone marrow (BM), peripheral blood, and fetal liver (FL) using immunoadherence t o a recently obtained antibody (SR-1) against the human KR. Cells isolated by this approach (designated SR-1Ad) have the morphology of blasts and represent 1% t o 4% of the original BM or FL populqtions. SR-1Ad cellsfrom either source are highly enriched in progenitors (12% t o 73%) and respond t o KL in distinct patterns. In SR-1Ad cells from BM, the greatest impact of KL stimulation is on burst-forming units-erythroid (BFU-E), whereas in SR1-Ad cells from FL, the most significant KL effect is on a mixed erythoridlnonerythroid progenitor (erythroid/macrophage, colony-forming unit-mix [CFU-Mix]). When antibody SR-1 is continually present in culture, it neutralizes the effects of added KL. Furthermore, in the absence of added KL, HE PROTO-ONCOGENE c-kit encodes a transmem-T brane tyrosine kinase receptor, highly homologous to other growth factor receptors with kinase activity such as c-fms or platelet-derived growth factor (PDGF).1-3 Both c-kit receptor (KR) and its newly cloned ligand, c-kit ligand (KL) (stem cell factor [SCF], mast cell growth factor [MGF], Steel play important roles in the development and differentiation of hematopoietic cells. Early hematopoietic progenitor cells appear to be dependent on KL for their survival and proliferation, whereas later progenitors are influenced by KL in synergy with other cytokines. KL by itself does not seem to trigger differentiation in these cells. However, in vivo data in W or Steel mice suggest that the KR and the KL may also play an essential role in the maturation of erythroid cells and mast cells.'o~ll Characterization of hematopoietic cells responding to KL has relied thus far on functional assays performed with either unpurified or enriched hematopoietic target cell population^.^^^"^ l5 The spectrum of cells in hematopoietic tissues expressing KR has not been defined. Thus, it is unclear where in the hematopoietic hierarchy KR is first expressed and whether cells from different lineages vary in their expression of KR. To define the spectrum of cells that are cellular targets for KL and to study their functional properties and their composite antigenic profile, we have chosen a direct approach for the isolation of KR expressing cells. For this purpose, we have used a recently isolated monoclonal antibody (MoAb) (SR-1) against human K R . I 6 Through immunoadherence or "panning" to SR-l-coated plates, we have isolated KR expressing cells from fetal liver (FL), adult bone marrow (BM), or peripheral blood (PB) and report on their functional properties and composite antigenic profile. Our data add new insights into the range of physiologic effects dictated by KRIKL interaction when KR expressing cells are used as targets.
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MATERIALS AND METHODS

BM aspirates and PB were obtained from normal volunteers under institutionally approved protocols and with informed
Cells.
it greatly diminishes the erythropoietin-and interleukin-3-dependent BFU-E growth in BM; whereas in FL, a wider spectrum of inhibition is observed, with CFU-Mix most severely curtailed. SR-1 Ad cells coexpress other progenitorassociated antigens in a combination reflecting the dominant presence of erythroid progenitors (high expression of CD34, DR, CD38, and Ep-1; low expression of CD33). Several cytoadhesion molecules, ie, q/& and q / p , integrins, and intercellular adhesion molecule 1 and homing cell adhesion molecule 1, are also coexpressed. Our data provide new information on the isolation and characterization of KR expressing cells from normal, adult, and fetal hematopoietic tissues. On these biologically relevant target cells, the impact of ligand-induced stimulation or antibody-mediated ablation of KR function has been gauged.
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consent. FL samples were provided by the Embryology Laboratory at the University of Washington (T.H. Shepard, Director). These specimens were obtained from therapeutic or spontaneous abortions and were distributed after mothers' informed consent. Heparinized BM aspirates and PB samples were subjected to Ficol-Hypaque density centrifugation, and mononuclear cells retrieved from interface layers were washed and resuspended in Iscove's modifield Dulbecco's medium (IMDM; GIBCO Labs, Grand Island, NY) medium with 5% serum (IMDM/fetal calf serum [FCS] ). FL fragments were cut into small pieces, dispersed with gentle pipetting, and passed through Nitex monofilament screen cloth (no. 35XX Tetko, Inc, Montrey Park, CA) to remove undispersed clumps and particles. Single cell FL cell suspensions obtained in this manner were washed further and resuspended in IMDM/FCS.
Immunoadherence ('>annmng''). "Panning" was essentially performed as previously described." Briefly, polystyrene plates were coated with SR-1 ascitic fluid (1:200 dilution in Tris pH 9.5). To these plates, either freshly prepared FL cell suspensions or BM mononuclear cells (BMMC) after an overnight adherence incubation step were added and incubated at 4"Cfor 40 minutes to 1 hour. The plates were washed gently with cold phosphate-buffered saline with 1% bovine serum albumin (PBSIBSA) to remove nonadherent cells, whereas adherent cells were recovered by vigorous pipetting of the entire plate surface with warm IMDMIFCS. PBMC were subjected to SR-1 "panning" after a negative selection step. For this purpose, PBMC were labeled with a cocktail of MoAbs against lymphoid, erythroid, and myeloid antigens (see below for specific antibodies) used in previously determined optimal concentrations. Following 30 minutes of incubation at 4"C, the cells were washed twice and subjected to "panning" on F(ab'), antimouse IgG-coated plates as described above. Nonadherent cells were washed in cold PBSIBSA, resuspended in IMDM/FCS, preincubated for 3 to 6 hours at 37°C to clear any antibody on their surface, and subjected to direct "panning" on SR-1 or anti-CD34-coated plates. Nonadherent and adherent cells were recovered as described above. In selected experiments, SR-1Ad cells were precleared of surface-bound antibody by preincubation, labeled with either anti-CD34 or anti-HLA-DR, and subjected to indirect "panning" using antimouse IgG-coated plates.
MoAbs used in this study were: anti-CD34 (HPCA-l), anti-CD7, anti-CD38, and anti-CD33 (LeuM9) all purchased from Becton Dickinson (San Jose, CA); another anti-CD33 (UF3) was provided by Dr I. Bernstein, University of Washington; Anti-VLA-4 (HP2/1) was kindly provided by Dr John Harlan, University of Washington (originally donated by Dr Sanchez Madrid); anti-LFA-1 was from Accurate Chemical Company (Westbury, NY); anti-intercellular adhesion molecule (anti-I-CAM) (BB2) and anti-HLA-DR (B10) were provided by Dr E. Clark, University of Washington. Anti-homing cell adhesion molecule (anti-H-CAM) (CD54) was kindly donated by Dr Brenda Sandmaier, Fred Hutchinson Cancer Research Center, and Ep-1 was produced in our 1aboratory.l8 MoAbs used for negative selection of PBMC were: against lymphoid antigens, anti-CD20 and antLCD3 (Becton Dickinson) and Cam Path-1 (generous gift of Dr T. Waldman, National Institutes of Health, Bethesda, MD); against erythroid antigens, SFL-23.6I9; against myeloid antigens, 58.8 produced by usz" and anti-CD33 (L4F3), anti-CD15 (lGlO), and 5F1 (the last three donated by Dr I. Bernstein) and anti-CDllb (60.1) supplied by Dr Harlan. The following hematopoietic growth factors and their concentrations in cell culture were used: granulocyte-macrophage colony-stimulating factor (GM-CSF) at 45 ng/mL, granulocyte-CSF (G-CSF) at 6 ng/mL, erythropoietin (Epo) at 2 UlmL, and interleukin-3 (IL-3) at 50 UlmL. All were generously supplied by Genetics Institute (Cambridge, MA). Anti-GM-CSF antibody was used at 2 p,g/mL, a concentration neutralizing over 100 U of GM-CSF, and anti-IL-3 at 1.2 Fg/mL, a concentration capable of neutralizing over 100 U of IL-3. Both antibodies were supplied by Dr Ken Kaushansky, University of Washington. Purified recombinant c-kit ligand (SCF or KL) was supplied by AMGEN (Thousand Oaks, CA) and was used at 50 to 100 ng/mL. Anti-c-kit receptor antibody, SR-1 (ascitic fluid), was used at a dilution of 1500.
BMMC, PBMC, and FL single cell suspensions, as well as populations selected after "panning," were plated in methylcellulose cultures for clonogenic progenitor assays. Unpurified cells were plated at 1 to 3 x 10s cellsiplate and purified cells were plated at 500 to 5,000 cells/plate. Methylcellulose cultures included the following components: 0.9% methylcellulose (Fisher Scientific, Pittsburgh, PA); 1% BSA (Calbiochem, San Diego, CA); 30% FCS (Intergen, Purchase, NY); lo-' mol/L 2-mercaptoethano1 (Eastman Kodak, Rochester, NY) in IMDM (GIBCO). To the above culture components the cytokines (Epo, IL-3, GM-CSF, G-CSF, and KL) were added, either alone or in various combinations. Other culture additives included anti-GM-CSF, anti-IL-3, and SR-1 antibodies. Methylcellulose plates were incubated for 10 to 16 days in 5% CO, in high humidity at 37°C. Erythroid bursts were counted at day 14 to 16 for adult cells (12 to 14 for FL cultures) as single or multiple units of at least 100 cells, with smooth outlines and high degree of hemoglobinization (redness). Colony-forming unit granulocyte-macrophage (CFU-GM) or CFUmacrophage (CFU-M) colonies were also identified morphologiGrowth factors and MoAbs.
Clonal cultures.
cally and evaluated at days 10 to 14 in the same plates. Mixed colonies (CFU-Mix) were defined here as colonies with at least some visible macrophage or granulocytic component (or both) and a hemoglobinized segment. Colonies containing combinations of granulocytic, macrophage, and megakaryocytic cells or other cells were counted as CFU-GM + M. CFU-erythroid (CFU-E) were evaluated in plasma clot cultures, a better system than methylcellulose for their growth and enumeration. Well-hemoglobinzed small clusters of 8 to 60 mature cells present at days 5 to 6 were counted as CFU-E. Plasma clot cultures contained the same components as methylcellulose cultures (except methylcellulose), plus 10% bovine citrated plasma (BCP; Irvine Scientific, Irvine, CA) and 10% beef embryo extract (BEE; GIBCO). Clots were stained with benzidine and hematoxylin.
In some experiments, selected cell populations were kept in suspension culture for several days before they were plated in clonal cell assays. Specifically, fractionated SR1-Adversus SR-1NAd cells from one BM sample were placed in suspension culture at the desired concentration, in the presence of IL-3 and KL or IL-3 alone in IMDM, 1% BSA, and 30% FCS. At desired time intervals, samples were taken for cell counting, morphologic observations, and replating in methylcellulose cultures.
Immunopuorescence/pow cytomeriy. Unpurified and purified populations were subjected to cytofluorometric analysis after labeling with several MoAbs. 
RESULTS
Isolation of KR expressing cells by 'kanning" with SR-I.
Adherent cells isolated after immune adherence and subsequent removal from SR-l-coated plates (SR-lAd, see Materials and Methods) represented 0.8% to 3.5% of the starting populations in five FL and three BM experiments. In cytocentrifuge preparations, SR-1Ad cells had predominantly a blast-like cell morphology, although small lymphocyte-like cells were also present (Fig 1) . Occasionally, small numbers of other cells, eg, megakaryocytes, were present, especially when BM cells were used. In contrast to FL and BM, in which either total unselected cells (FL) or mononuclear cells (BM) were used for SR-1 "panning", PBMC were subjected to a negative selection step (as described in Materials and Methods) before the SR-1 "panning". This step enhanced the successful outcome of the subsequent "panning" on SR-l-coated plates, although such a maneuver can theoretically lead to altered progenitor representation and affect the total progenitor yield. SR-1Ad cells in the PB experiment represented 0.1% of the original nonad- herent PBMC population and 3.4% of the negatively selected population.
SR-IAd cells are highh enriched in hematopoietic progenitors.
To test the concentration of progenitors in SR-lAd, SR-lNAd, and the starting population, we plated these in MC cultures at appropriate concentrations. Data from four FL and two BM experiments are shown in Fig 2. The proportion of progenitors of all types present in SR-!Ad cells ranged from 12% to 73% in four FL and from 11% to 43% in two BM experiments, whereas SR-1NAd and original cells ranged from 0.08% to 1.15% (FL) to 0.03% to 0.55% (BM). Thus, progenitors in SR-1Ad cells were enriched up to 400-fold compared with SR-1NAd cells.
To examine the individual progenitor categories present in SR-1Ad cells and their response to cytokines, we cultured these cells with a given cytokine or various combinations of cytokines. The number and types of colonies produced are presented in Fig 3 and Table 1 . The results appear to be dependent both on the combination of cytokines used and on the tissue of origin. When BM SR-1Ad cells were used, addition of KL to a combination of cytokines nearly doubled the number of both pure erythroid bursts and mixed erythroid/nonerythroid bursts (Table 1) . In fact, in the presence of Epo, KL alone could stimulate over 80% of all erythroid colonies seen with a combination of all other cytokines. In addition to its effect on the number of bursts, the addition of KL had a dramatic impact on burst size: the majority of bursts attained macroscopic (>0.3 mm) size in culture. In SR-1Ad cells from FL, however, the greatest impact of KL was in uncovering a mixed erythroid/ macrophage progenitor resulting in a significant increase in mixed erythroid/nonerythroid colonies (Fig 3, Table 1 ). Pure erythroid bursts responded to KL with an increase in size, but remained unchanged or slightly diminished in number. Addition of IL-3 or GM to SR-1Ad from FL with or without KL mainly increased the number of GM + M colonies (Table 1) .
To further examine the proliferative potential of progenitors present in SR-1Ad versus SR-1NAd BM cells, we cultured a given inoculum from each (1 x los SR-1Ad; 20 x 10' SR-1NAd) in suspension culture in the presence of both IL-3 and KL or IL-3 alone. Medium was partly renewed every 2 days and an aliquot used for cell counts and Tables 2 and 3. As  the data in Tables 2 and 3 show, the presence of SR-1 in culture appeared to have affected colony growth beyond its expected neutralization of the added KL. For example, a profound inhibitory effect on Epo-or Epo + IL-3-dependent burst-forming unit-erythroid (BFU-E) growth was exerted by SR-1 ( Table 2) . When additional cytokine combinations were present, more BFU-E seemed to escape the inhibiting action of SR-1. Nonerythroid colonies were less affected. In FL experiments (Table 3) , however, SR-1 inhibited erythroid and nonerythroid colonies alike, with CFU-Mix most severely curtailed. It is notable that surviving BFU-E-derived colonies in SR-l-containing cultures are much smaller in size than their counterparts in the absence of SR-1 in both BM and FL. These data would indicate that SR-1 continues to exert its effect throughout burst development. To test whether the addition of SR-1 affects cell viability, we performed the Trypan blue exclusion test after 2 , 6 , and 24 hours in the presence or absence of SR-1. Based on this assay, no differences were found among cell suspensions containing or not containing SR-1. Furthermore, to test whether serum components (or possibly KL present in serum) were neutralized by SR-1, thereby indirectly affecting the cells' proliferative competence, we tested the effects of both KL and SR-1 on SR-1Ad cells from FL in serum-deprived cultures (serum-deprived medium provided by G. Migliaccio and prepared as described).'l Addition of KL in these cultures (Table 3) had similar effects to those described for serum-containing cultures as the predominant effect of SR-1 was on mixed colonies and on the size of surviving erythroid bursts. Thus, it was unlikely that SR-1 was inhibiting growth through effects on serum KL or on other factors present in serum.
Effect of continuous presence of SR-1 in culture.
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Given the effect of SR-1 on burst size and the presence of CFU-E among SR-1Ad cells ( Table 2) , we were surprised to see that CFU-E number was not changed in methylcellulose'6 or plasma clot cultures by the addition of KL or by the SR-1 antibody ( Table 2) . Nevertheless, although hemoglobinized colonies of up to -40 cells, evaluated in plasma clots at day 5 to 6, seemed unaffected, there was a 10% to 20% reduction in larger hemoglobinized colonies of 50 to 100 cells present on the same day (data not shown).
To test the spectrum of surface antigens expressed, we labeled SR-1Ad cells isoAntigenicprofile of SR-1Ad cells. 6 ) and FL (data not shown), spectacular differences between SR-1Ad and SR-1NAd cells were observed with anti-CD34, anti-DR, and anti-CD38. SR-1Ad cells isolated from PB also showed significant ( > 50%) coexpression of CD34 antigen (data not shown), indicating that the relationship between CD34 and KR expression is maintained in circulating progenitors. In contrast to CD34, expression of CD33 among SR-1Ad cells was very moderate in BM ( Fig  6) and was even weaker in FL (data not shown). However, expression of Ep-1 was very high in SR-1Ad cells from both BM (Fig 6) and FL (data not shown). Diminished expression of CD33 together with high expression of EP-1 and CD34 very likely reflect the predominance of erythroid progenitors among SR-1Ad cells. In two experiments we attempted to pursue further the relationship between the phenotype of progenitors present among SR-1Ad cells and their relative expression of CD34 or HLA-DR antigens. For this purpose we subfractionated SR-1Ad cells (by secondary "panning") into subsets containing cells highly positive for CD34 or DR antigens (CD34Ad or DR-Ad) compared with subsets with low or no positivity for these antigens (CD34NAd, DR-NAd) ( Table 4 ). As seen in Table 4 , there was a preponderance of pure and mixed erythroid colonies among SR-1Ad cells with low expression of CD34 or DR. On the contrary, nonerythroid colonies predominated in subsets with high expression of CD34 or DR. These results would suggest that a significant segment of erythroid progenitors may express only KR with low or no expression of CD34 or DR. Furthermore, in one PB experiment we compared the type of progenitors present in SR-1Ad cells with those in concurrently isolated CD34Ad ( Table 5) . In this experiment, the ratio of erythroid to nonerythroid progenitors was again lower in CD34Ad cells compared with SR-1Ad cells, but the differences were less striking than in FL. It is possible that the negative selection step in this PB experiment has disturbed the natural relationships of various progenitors present in PB by eliminating preferentially nonerythroid progenitors, because several of the antibodies used were previously found to react with GM progenitor cells, eg, 58.8" and CD33.'.23 SR-1, although highly positive in SR-1Ad cells, was negative (<0.1%) on SR-1NAd cells (Fig 7) . Because the For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From 
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A -+-- SR-1NAd population is dominated by differentiating or maturing cells, the data suggest that KR is not detectable among morphologically recognizable precursor cells, including erythroblasts. This notion was independently confirmed when purified erythroblasts obtained by "panning" on SFL-23.6-coated platesz4 appeared negative with SR-1 (data not shown). However, when erythroid cells present in young erythroid bursts in culture were tested, a significant positivity (-17% SR-1') was found'' (data not shown). These data would indicate that early BFU-E progeny or CFU-E or early proerythroblasts may express KR, in contrast to late erythroblasts predominant among SFL-23.6-adherent cells. The presence of minor SR-1 reactivity in SR-1NAd cells, as shown in Fig 6, was not finding. This notion is reinforced by the fact that total BMMC also showed an increased proportion of SR-1(+) positive cells after overnight incubation in the presence of cytokines (data not shown).
In addition to the aforementioned antigens, the expression of several cytoadhesion molecules, recently documented to be present on early erythroid progenitors," was also tested. These cytoadhesion molecules included two expressed in SR-1NAd cells. The profile of integrin expression in SR-1Ad cells from BM was similar with the exception that LFA-1 was also expressed highly in SRlNAd cells. The latter possibly reflects differences in the composition of nonprogenitor cells between the two sources, ie, mostly erythroid cells in FL versus mostly myeloid cells in BM.
DISCUSSION
Growth factor receptors on hematopoietic cells, such as IL-3 or GM-CSF receptors, are expressed in low numbers and a low rate of occupancy is sufficient to elicit their biologic effect.26-28 Therefore, physical isolation of hematopoietic progenitor cells through antiligand or antireceptor antibodies is difficult to achieve. Most previous successful isolations of progenitors have relied on the use of MoAbs against surface antigens of as yet unassigned function, such as CD34.29.33 In the present study, using a single-step immunoadherence on anti-KR antibody (SR-1)-coated plates, we have successfully isolated a highly enriched subset of hematopoietic progenitors characterized by high KR expression and distinct responses to KL.
Average estimates of KR molecules in unpurified BM cells, based on equilibrium binding studies with radioactive ligand, appear to be within the same low range ( < 1,000, V. Broudy, unpublished data) as those published for IL-3 or GM-CSF receptors. However, these estimates, performed on heterogeneous populations containing target and nontarget cells, are likely to underrepresent the true receptor number in target cells. In addition, heterogeneity in receptor expression may be present among target cells.'6 Because immune adherence demands relatively high receptor density and SR-1 "panned" cells appear to be highly enriched in progenitors, one may suggest that c-kit receptors may reach peak expression at the level of hematopoietic progenitors. This high expression in turn could account for our success in isolating progenitor cells and is consistent with fluorescent data on SR-1 showing very low positivity (2% to 4% SR-I+) in BMMC and higher positivity (12% to 17% SR-l+) in the "blast" window where the majority of progenitor cells reside.I6 Analogous conclusions have also been reached with regard to GM-CSF receptors, when unpurified cells were compared with enriched progenitor targets (300 to 500 v 3,000 receptors/cell, re~pectively).'~ Addition of recombinant KL to SR-1Ad cells in clonal cultures elicited distinct response patterns that depended on the tissue from which the cells were isolated. For example, in BM the bulk of the increase in total progenitors induced by KL is made up of pure erythroid progenitors (BFU-E). A characteristic increase in burst size also accompanies this effect. In FL, however, a bipotent (erythroidmacrophage) progenitor is induced in great numbers by KL, whereas erythroid bursts were increased in size but not in number. Thus, recruitment of CFU-Mix appears to be a distinguishing feature of KL not shared by IL-3 or GM. The physiologic significance of the effect of KL on the growth of erythroid/macrophage FL progenitors remains unclear. In this context, the recently presented evidence that ligand binding to c-kit or c-fms receptor may activate overlapping signal transduction pathways is of interest.35
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In addition to specific patterns of cytokine response in clonal cultures, studies of SR-1Ad and SR-1NAd cells in suspension cultures suggest that SR-1 can segregate two functionally distinct populations. Amplification of progenitor cells in suspension cultures driven by KL was observed only with SR-1Ad cells. This amplification may represent either an effect on preprogenitors (pre-CFU) or on existing progenitors, which would undergo proliferative rather than differentiative divisions, or on both. High progenitor yield for several weeks in culture, much longer than our 2-week observation period, would favor an effect on preprogenitors. However, our current data do not permit this distinction. Furthermore, whether expression of KR, and thereby the influence of KL, extends beyond the level of preprogenitors to the level of the pluripotent cell or the ultimate repopulating cell has not been addressed as yet. Further experimentation in a transplantation model would be necessary to answer these questions.
The negative effect of SR-1 in culture, inhibiting colony growth beyond the neutralization of added KL, provides additional insights into the biologic role of KL in hematopoiesis. Pure and especially mixed erythroidinonerythroid growth was severely curtailed by the action of SR-1 in the absence of added KL. GM-or IL-3-dependent fetal CFU-GM growth was also significantly inhibited by SR-1, indicating a high sensitivity of all fetal progenitors to the inhibiting effects of SR-1. This inhibitory effect of SR-1, noted in our previous experimentsI6 and with another anti-KR Ab? could be attributed to its direct effects on cell viability or indirect effects through neutralization of serum factors. However, no evidence supporting either of these possibilities was found. Instead, we believe that the reduction in the influence of the other cytokines (ie, Epo or IL-3) in culture, brought about by the abrogation of KR function, represents another example of cross communication of cytokine receptors in hematopoietic progenitors. Ample precedent for receptor modulation by heterologous ligands already exists in the literat~re.~' Most relevant are recent observations of KR downregulation by Epo, IL-3, and GM-CSF in hematopoietic lines with functional receptors for these cyt~kines.~' Unfortunately, the effect of KL on the IL-3 receptor or Epo receptor expression in these cells was not e~amined.~' The mechanism(s) responsible for the effect of other cytokines on KR, as well as the influence of abrogation of KR function on other cytokines, as observed here, and the physiologic significance of these effects, remains to be delineated. In this context, it is of further interest that targeted ablation of c-myb in mice39 resulted in inhibition of fetal progenitors qualitatively similar to one exerted by SR-1. Involvement of c-myb gene product in c-kit regulation may explain these data.
In addition to influencing the number of BFU-E in culture, SR-1 appears to inhibit the growth of BFU-E progeny, because it reduced the size of surviving erythroid bursts; this was its main effect when added to MC cultures in a delayed fashion.16 Thus, SR-1 continues to exert its influence throughout burst development. Consistent with this view is the finding of SR-1(+) cells within burst populations. However, once cells have reached the CFU-E stage in vivo, they appear to be influenced neither by KL nor by SR-1. Lack of proliferative effects of KL on CFU-E, many of which express KR (Table 2) , may be due to the presence of a modified form of receptor or modified intracellular signaling at this stage, so as to exert effects other than proliferative.
Examination of the antigenic profile of SR-1Ad cells shows coexpression in these cells of KR and several other molecules that have been previously found to be present on progenitors, such as CD34, HLA-DR, or CD38. The KR and CD34 relationship was also present in SR-1Ad cells isolated from PB. In contrast to CD34, CD33 is not highly expressed in SR-1Ad cells from either BM or FL. Diminished expression of CD33 was previously noted in erythroid progenitors (BFU-E)." By contrast, Ep-1 is preferentially expressed by erythroid progenitors" and it was highly positive on SR-1Ad cells. Thus, this composite profile is consistent with the interpretation from the culture data that erythroid progenitors predominate in SR-1Ad cells. In addition to the aforementioned antigens, SR-1Ad cells express several cytoadhesion molecules, specifically aL/& (CDlla, LFA-l), a,/P, (VLA-4), I-CAM (CD55), and H-CAM (CD44). Inasmuch as participation in adhesive interactions has been also proposed for CD34 and for the membrane form of KL,,' this complement of cytoadhesion molecules on SR-1Ad cells may engage progenitors, possibly in overlapping fashion, in interactions with other cells in their microenivronment and with extracellular matrix. The hierarchical relationships in the expression of these other molecules in relation to KR (eg, is CD34'SR-1-or CD34'SR-1' a more ancestral cell to CD34-SR-1'?) could be further tested using fluorescence-activated cell sorter (FACS) subfractionation of SR-1-purified cells.
In summary, using a one-step purification approach we have isolated a subset of hematopoietic progenitor cells characterized by high expression of KR, high concentration of progenitors, and distinct responses to KL. The dominant expression of KR by erythroid progenitors, together with the preferential influence of added KL on erythroid growth (pure and mixed) and their abrogation by SR-1 in culture, underscore the importance of the c-kit receptor and its ligand in erythropoiesis.
